Targeted therapies include trastuzumab (herceptin), pertuzumab (perjeta) and lapatinib (tykerb). Different types of drugs have been developed that target the her2 protein Metastatic breast cancer is cancer that has spread to other parts of the body away from the breast, such as the bones or liver. Herceptin trastuzumab (herceptin) was the first targeted therapy approved by the fda for her2+ breast cancer It’s a type of biologic drug called a monoclonal antibody. This article explains how these therapies work, side effects to expect, and what’s on the horizon.
Targeted therapies—a form of precision medicine—have represented some of the most important breakthroughs in breast cancer research Today, oncologists have numerous targeted therapies to treat patients including Endocrine therapy to target the estrogen receptor One type of biologic targeted therapy currently being studied is monoclonal antibodies If cancer cells are positive for the her2/neu receptors that means there is an overabundance of. In the case of her2+ breast cancer with positive hormone receptors (luminal b), endocrine therapy is incorporated into the trastuzumab and chemotherapy administration [13, 14]
OPEN
